First Horizon Advisors’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$12.9K Sell
625
-58
-8% -$1.19K ﹤0.01% 1580
2025
Q1
$13.4K Sell
683
-159
-19% -$3.33K ﹤0.01% 1491
2024
Q4
$17.6K Buy
842
+31
+4% +$681 ﹤0.01% 1381
2024
Q3
$19.8K Sell
811
-18
-2% -$481 ﹤0.01% 1360
2024
Q2
$20.8K Hold
829
﹤0.01% 1256
2024
Q1
$24.8K Sell
829
-185
-18% -$5.43K ﹤0.01% 1259
2023
Q4
$32.3K Sell
1,014
-113
-10% -$3.55K ﹤0.01% 1129
2023
Q3
$39.7K Buy
1,127
+919
+442% +$35K ﹤0.01% 949
2023
Q2
$7.91K Buy
208
+91
+78% +$3.63K ﹤0.01% 1634
2023
Q1
$4.42K Sell
117
-103
-47% -$3.96K ﹤0.01% 1848
2022
Q4
$9.32K Buy
220
+48
+28% +$1.98K ﹤0.01% 1596
2022
Q3
$5K Sell
172
-313
-65% -$11K ﹤0.01% 1767
2022
Q2
$16K Sell
485
-1,105
-69% -$35.8K ﹤0.01% 1374
2022
Q1
$58K Buy
1,590
+164
+12% +$5.63K ﹤0.01% 598
2021
Q4
$55K Buy
1,426
+14
+1% +$584 ﹤0.01% 885
2021
Q3
$61K Buy
1,412
+1,376
+3,822% +$61.8K ﹤0.01% 824
2021
Q2
$1K Buy
+36
New +$1.39K ﹤0.01% 1871
2020
Q4
Sell
-24
Closed 1500
2020
Q3
$0 Sell
24
-572
-96% -$20.7K ﹤0.01% 1469
2020
Q2
$20K Hold
596
﹤0.01% 804
2020
Q1
$12K Buy
+596
New +$13.3K ﹤0.01% 890

Other funds holding GMAB

First Horizon Advisors's GMAB Position: Q2 2025 in Review

First Horizon Advisors reduced its Genmab (GMAB) stake by 8.5% in Q2 2025, selling an estimated $1.19K and leaving 625 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1580.

First Horizon Advisors first reported a position in GMAB in Q1 2020 and has held it in 20 quarters since. The position peaked at $61K in Q3 2021. 218 funds tracked by Wall St. Rank hold GMAB as of Q2 2025.

  • First Horizon Advisors held 625 shares of Genmab worth $12.9K as of Q2 2025.
  • First Horizon Advisors sold 58 Genmab shares in Q2 2025, an estimated $1.19K.
  • Genmab made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1580 holding.
  • First Horizon Advisors first reported a position in Genmab in Q1 2020 and has held it in 20 quarters since.
  • First Horizon Advisors's Genmab position peaked at $61K in Q3 2021.
  • 218 funds tracked by Wall St. Rank held Genmab as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.